Executive Committee

The Executive Committee both manages and represents ERS by directing and conducting the general activities of the Society on behalf of the General Assembly. The Executive Committee provides an annual report on all activities to the General Assembly.

Committee members

Monika Gappa - profile image
Monika Gappa
President

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
Aimmune Lecture feeB
NestleLecture feeB
SanofiLecture fee, advisory committeeC
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
InfectopharmClinical trial feesB
ALK AlbelloClinical Trial feesB
NestleUnrestricted grant, investigator initiated researchD
SanofiClinical trial feesC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Carlos Robalo Cordeiro - profile image
Carlos Robalo Cordeiro
Past President

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work
Company Area Product Amount of funds received*
Boehringer IngelheimILDNintedanibB
Personal Benefits
Company Purpose of Payment Amount of funds received*
Boehringer IngelheimAdvisory/LecturesB
MSDAdvisory/LecturesB
AstraZenecaAdvisory/LecturesB
GSKAdvisory/LecturesB
SanofiAdvisory/LecturesB
PfizerAdvisory/LecturesB
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Silke Ryan - profile image
Silke Ryan
President Elect

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
FitbitUnrestricted grantD
Novo NordiskUnrestricted grantD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Joanna Chorostowska-Wynimko - profile image
Joanna Chorostowska-Wynimko
Vice President

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
MSDlecturesB
Pfizerlectures; advisory committeeB
AstraZenecalectures; advisory committeeB
Takedalectures;B
Amgenlectures;B
Adamedlectures;B
Grifolslectures;B
CSL Behringlectures;advisory committeeB
Mereo Biopharmaadvisory committeeB
Personal Travel Grants or expenses for conferences etc.
Company Purpose and Nature of Benefit Amount of funds received*
MSDconferenceB
AmgenconferenceB
Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
Biocartisdonated to my InstitutionA
Pfizerdonated to my InstitutionB
AstraZenecareserach grant donated to my InstitutionD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Judith Garcia-Aymerich - profile image
Judith Garcia-Aymerich
Secretary General

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
AZMember of advisory boardB
ChiesiSpeakerA
ChiesiChapter writerA
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
AZResearch project on COVIDC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Peter Wijkstra - profile image
Peter Wijkstra
Treasurer

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work
Company Area Product Amount of funds received*
Philips Chronic Ventilatory Support ventilator B
Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Hilary Pinnock - profile image
Hilary Pinnock
Education Council Chair

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
TEVA pharmaceuticalsHonorarium for a non-promotional talk in a sponsored symposium at the ERS 2022B
Sandoz pharmaceuticalsHonorarium for a non-promotional talk in a sponsored symposium at the PCRS 2022B
Boehringer-IngelheimHonorarium for a non-promotional talk in the UK Respiratory Academy 2020B
Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

None

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Nicolas Roche - profile image
Nicolas Roche
Science Council Chair

Declaration of Interests

Annual Declaration of Interest 2023-2024

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
AstraZenecaAd board, consultancyB
GSKAd board, consultancy, steering committeeC
ChiesiAd board, consultancy, presentationC
BiosencyconsultancyA
MenarinipresentationB
Sanofiad boardC
NOvartisAd boardB
ZambonpresentationB
Tevaad boardA
Pfizerad boardA
MSDpresentationA
ALKpresentationB
Personal Travel Grants or expenses for conferences etc.
Company Purpose and Nature of Benefit Amount of funds received*
ChiesiCPLFA
Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
GSKresearchD
PfizerresearchD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Barbara Hoffmann - profile image
Barbara Hoffmann
Advocacy Council Chair

Declaration of Interests

Annual Declaration of Interest 2023-2024

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits

None

Personal Travel Grants or expenses for conferences etc.

None

Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
DFGResearch grantD
Umwelt- und NachbarschaftshausResearch grantD
UmweltbundesamtResearch grantD

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Dimitris Kontopidis - profile image
Dimitris Kontopidis
Chair of the European Lung Foundation

Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.

He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.


Sara Tomassetti - profile image
Sara Tomassetti
Publications Council Chair

Declaration of Interests

Annual Declaration of Interest 2022-2023

1 - Personal interests

Regular Paid Consultancy Work

None

Personal Benefits
Company Purpose of Payment Amount of funds received*
Roche; Boeringher-inghelheim; ERBEoccasional consultancyA
Personal Travel Grants or expenses for conferences etc.
Company Purpose and Nature of Benefit Amount of funds received*
Boehringer-Ingelheimtravel grantsB
Shares in any Relevant Companies (excluding mutual funds)

None

2 - Non-Personal interests

Company Nature of Support Amount of funds received*
Astra Zeneca; Roche; Boehringer-inghelheim; ERBE; PulmoniXspeaker's fees, research supportC

3 - Other Interests that may be seen as potential conflicts

None

4 - Tobacco-Industry related Conflicts of Interests

No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.


*Funds Code Legend
A B C D
less than € 1'000 € 1001 - € 5'000 € 5'001 - € 20'000 more than € 20'000
Sara Cuevas Ocaña  - profile image
Sara Cuevas Ocaña
Early Career Members Committee Chair

All ERS Assembly Heads are also members of the Executive Committee.